Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Advanced Accelerator Applications Plans to Build Second US Manufacturing Site in Indianapolis
Advanced Accelerator Applications plans to build a new manufacturing facility for currently approved therapy and pipeline drug candidates in Indianapolis The expansion would be the second US manufacturing site for targeted radioLigand therapy
WACKER Announces Plans to Invest in Amsterdam Biotech Site
WACKER has recently announced investment plans for its production facilities of biologics, LMPs live microbial products and vaccines located at Amsterdam site, at a middoubledigit millioneuro amount
Marken Expands GMP Facility in Frankfurt
Marken has announced its plans to double the space of GMP facility by expanding in Frankfurt to meet the frozen room storage capabilities in anticipation of the COVID19 vaccine and storage needs
Nephron Pharmaceuticals Corporation Invests US$215m in New Projects in Lexington County
Nephron Pharmaceuticals Corporation has announced major investment plan in Lexington County, where it is headquartered, with an investment of US$215 million
SEKISUI Diagnostics Invests US$ 18.6 million in cGMP Microbial Capacity Expansion
Sekisui Diagnostics announced its plans to invest US$ 186 million 144 million in biopharma CDMO business to expand cGMP microbial capacity located at its existing site in Maidstone
SCA Pharma to Build a New Production Facility in Little Rock
SCA Pharma announced its plans to expand operations with the construction of a new production facility in Little Rock, with an investment of over US$10 million, which includes renovation of the existing facility and building a new facility
Emergent BioSolutions Invests US$75 million in New Manufacturing Unit
Emergent BioSolutions has announced US$75 million investment plan to expand viral vector and gene therapy capabilities in its facility at Canton, Massachusetts This investment is part of the companys bid to strengthen its Contract Development
Fujifilm Invests US$83m to Expand Biotechnologies Microbial Capacity in UK
FUJIFILM Corporation plans to invest US$83 million dollars to expand microbial production capacity of FUJIFILM Diosynth Biotechnologies FDB
FUJIFILM Diosynth Biotechnologies to Construct New Biocampus in UK
FUJIFILM Diosynth Biotechnologies FDBunveiled its plans for the construction of a new US$1905m 145m BioCampus at Billingham, UK
Thermo Fisher Opens New Commercial Manufacturing Site in Plainville, USA
Thermo Fisher Scientific Inc, has recently announced its plans to expand its facility for increasing capacity of viral vector development and manufacturing services located
